Acoziborole could change that. The new drug works for both early and advanced stages of the most common form of sleeping ...

European drug regulators are endorsing a new and simpler treatment for sleeping sickness, in what could be a giant boost to efforts to eliminate the disease.

A single-dose pill called acoziborole cured most sleeping sickness patients in a major trial, even when the parasite reached the brain.

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both ...

A handful of patients in Ethiopia, Malawi, Tanzania, Zambia, and Zimbabwe, as well as foreign travellers, have now been treated with a medicine that is revolutionizing care for patients with ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of ...

Once the bane of sub-Saharan Africa, sleeping sickness is agonisingly close to being wiped out, but only if countries -- and donors -- keep up their guard, say scientists. But a coordinated global ...